Jpmorgan Chase & CO Form 4 insider transactions

Douglas B Petno, Co-President; CEO CIB of Jpmorgan Chase & Co, reported multiple transactions in common stock on November 12, 2026.

Stephen B Burke, a Director of Jpmorgan Chase & Co, reported a transaction in 30,000 shares of common stock on October 14, 2026.

Phebe N Novakovic, a Director of Jpmorgan Chase & Co, received 121 shares of common stock on September 30, 2026.

Virginia M Rometty, a Director of Jpmorgan Chase & Co, received 121 shares of common stock on September 30, 2026.

Mellody L Hobson, a Director of Jpmorgan Chase & Co, received 136 shares of common stock on September 30, 2026.

Stephen B Burke, a Director of Jpmorgan Chase & Co, received 170 shares of common stock on September 30, 2026.

Robin Leopold, Head of Human Resources of Jpmorgan Chase & Co, sold 2,500 shares of common stock on September 10, 2026 for $352.81 per share.

Robin Leopold, Head of Human Resources of Jpmorgan Chase & Co, sold 2,500 shares of common stock on August 11, 2026 for $361.41 per share.

Stacey Friedman, General Counsel of Jpmorgan Chase & Co, reported a transaction in 166 shares of common stock on July 27, 2026.

Douglas B Petno, Co-President; CEO CIB of Jpmorgan Chase & Co, reported a transaction in 864 shares of common stock on July 24, 2026.

JPMorgan Chase & Co. executive Marianne Lake reported a stock transaction on June 25, 2026, as per SEC Form 4 filing.

Virginia M. Rometty, a Director at JPMorgan Chase & Co., reported a transaction involving the acquisition of common stock.

Phebe N. Novakovic, a Director at JPMorgan Chase & Co., reported a transaction involving the deferral of quarterly retainer fees into company common stock.

JPMorgan Chase & Co. Director Mellody Hobson has reported a transaction involving the deferral of her quarterly retainer, payable in common stock.

JPMorgan Chase & Co. director Stephen B. Burke acquired shares of common stock on June 30, 2026, as part of a deferred compensation plan.

JPMorgan Chase & Co. reports that Chief Operating Officer Jennifer Piepszak was granted 60,214 Restricted Stock Units (RSUs) with a vesting date of June 24, 2029.

JPMorgan Chase & Co. reports that Co-President and CEO CCB, Troy L. Rohrbaugh, was granted 90,321 Restricted Stock Units (RSUs) on June 24, 2026, vesting on June 24, 2029.

Douglas B. Petno, Co-President and CEO CIB at JPMorgan Chase & Co., reported the acquisition of 90,321 Restricted Stock Units (RSUs) on June 24, 2026.

Mary E. Erdoes, CEO of Asset & Wealth Management at JPMorgan Chase, reported the grant of 60,214 Restricted Stock Units (RSUs) with a cliff-vesting date of June 24, 2029.

JPMorgan Chase & Co. and DNT Asset Trust disclosed the internal transfer of 7,178 Series W-7 Variable Rate Muni Term Preferred Shares of BlackRock MuniHoldings Fund, Inc. into a trust.

JPMorgan Chase & Co. General Counsel Stacey Friedman sold 5,468 shares of common stock on May 20, 2026, pursuant to a Rule 10b5-1 trading plan.

JPMorgan Chase CEO of Asset & Wealth Management Mary Erdoes sold 6,648 shares of company stock on May 15, 2026.

JPMorgan Chase & Co. CEO of Consumer and Community Banking Marianne Lake reported the sale of 6,427 shares of common stock.

JPMorgan Chase Co-CEO Douglas Petno reported a series of stock transfers and a sale of 5,659 shares of common stock.

JPMorgan Chase & Co. Chief Information Officer Lori A. Beer sold 3,165 shares of common stock on May 15, 2026.

JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum sold 3,022 shares of common stock on May 5, 2026.

Chief Risk Officer Ashley Bacon sold 4,070 shares of JPMorgan Chase & Co. common stock on May 5, 2026.

JPMorgan Chase & Co. Chief Operating Officer Jennifer Piepszak sold 4,919 shares of common stock on May 5, 2026.

JPMorgan Chase & Co. Chief Operating Officer Jennifer Piepszak sold 9,136 shares of common stock on April 15, 2026.

JPMorgan Chase Co-CEO of Corporate & Investment Bank Douglas Petno sold 5,660 shares of common stock on April 15, 2026.